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Available online 22 July 2012Abstract Chromosomal aneuploidies are responsible for severe human genetic diseases. Aiming at creating models for such
disorders, we have generated human embryonic stem cell (hESC) lines from pre-implantation genetic screened (PGS) embryos.
The overall analysis of more than 400 aneuploid PGS embryos showed a similar risk of occurrence of monosomy or trisomy for
any specific chromosome. However, the generation of hESCs from these embryos revealed a clear bias against monosomies in
autosomes. Moreover, only specific trisomies showed a high chance of survival as hESC lines, enabling us to present another
categorization of human aneuploidies. Our data suggest that chromosomal haploinsufficiency leads to lethality at very early
stages of human development.
© 2012 Elsevier B.V. All rights reserved.IntroductionThe occurrence of chromosome numerical disorders in humans
is a common phenomenon during early embryonic develop-
ment (Delhanty, 2005), and is responsible for as much as 65%
of clinically recognized miscarriages (Wilton, 2002). Whole-
chromosome imbalances can be frequently detected in in
vitro fertilization (IVF) procedures by preimplantation genetic⁎ Corresponding author at: Regenerative Medicine Institute, Cedars-
Sinai Medical Center, Los Angeles, California, 90048, USA.
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http://dx.doi.org/10.1016/j.scr.2012.07.002screening (PGS) (Mir et al., 2010; Munne et al., 2010; Li et al.,
2005; Baart et al., 2006; Rubio et al., 2007). These aberrations
can originate from meiotic errors in the gametes, resulting in
homogeneous aneuploid embryos, or from post-zygotic errors
produced during the first mitotic divisions, leading to mosaic
embryos composed of euploid and aneuploid cells, or cells
carrying different aneuploidies (Li et al., 2005; Colls et al.,
2007; Vanneste et al., 2009).
Aneuploid embryos can be used to derive aneuploid hESC
lines for modeling genetic disorders. We have previously
reported that about 2/3 of the cell lines derived from
aneuploid embryos resulted euploid following expansion in
culture, and about 1/3 remained aneuploid (Biancotti et
219The in vitro survival of human monosomies and trisomies as embryonic stem cellsal., 2010; Narwani et al., 2010; Lavon et al., 2008). This
occurrence may be explained by the high incidence of
mosaicism within cleavage-stage embryos, and a selection
in favor of euploid cells in culture. Such bias against aneuploid
cells also takes place in vivo, and is evidenced as a significantly
higher rate of aneuploidy in preimplantation blastocysts when
compared to embryos at post-implantation stages (Rubio et al.,
2007; Fragouli et al., 2008).
In the present work, we report the analysis of more than
400 aneuploid PGS embryos, and show that despite the
similar occurrence of trisomy and monosomy on any specific
chromosome, hESC lines derived from these embryos display
a categorical bias toward trisomies of autosomes.
Materials and methods
Derivation of hESC lines from PGS-analyzed blastocyst
Derivation of hESCs was performed under the approval of the
Stem Cell Research Oversight Committee at Cedars-Sinai
Medical Center, according-to-protocol # 9647: “Establishment
of hESCs from Genetically Abnormal and Spare IVF-Derived
Embryos.”
The trophectoderm (TE) was manually removed by dissec-
tion utilizing ultra sharp splitting blades (Bioniche Animal
Health USA, Athens, GA). The use of manual cut increased the
success of derivation of hESC lines. The subsequent steps of
derivation were performed as described before (Lavon et al.,
2008).
Karyotype analysis
Five wells of a 6 well plate of rather confluent hESCs in log
growth phase were fed with fresh media the night before
the procedure. Next morning, cells were treated with
100 ng/ml of KaryoMAX colcemid (Invitrogen, Carlsbad,
CA) for 30 min in incubator at 5% CO2. Then, cells were
collected by trypsinization, treated with hypotonic solution
and fixed with methanol:acetic acid 3:1 and kept at −20 °C
until analysis. Chromosomes were classified according to
the International System for Human Cytogenetic Nomencla-
ture (ISCN), using the standard G banding technique.
Staining for markers of undifferentiation
To reveal alkaline phosphatase enzymatic activity, hESCs
grown on 12 well plates were fixed with a solution of citrate-
acetone-formaldehyde, and stained using the 86R-1KT kit
(Sigma-Aldrich, St. Louis, MO) following manufacture's proto-
col. For immunocytochemistry, hESCs grown on coverslips were
incubated with a mixture of mouse IgG anti-human Oct 3/4
(1:20) and mouse IgM anti-human TRA-1-60 (1:100) antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA), and revealed with
a combination of either goat anti-mouse IgG-PE (1:300) and
goat anti-mouse IgM-FITC (1:200) or goat anti-mouse IgG-FITC
(1:300) and goat anti-mouse IgM-PE (1:200). Bis-benzimide
(Hoechst 33258; Sigma-Aldrich, St. Louis, MO) was used for
nucleus staining. Flow cytometry analysis was carried out by
incubating cells with either mouse IgG anti-human SSEA4
(1:50) or mouse IgM anti-human TRA-1-60 (1:50) and thengoat anti-mouse IgG-FITC (1:200) or goat anti-mouse IgM-FITC
(1:200) (all from Santa Cruz Biotechnology, Santa Cruz, CA) on
ice for 20 min each. Following washes, cells were analyzed
immediately in a FACSCalibur analyzer (Becton-Dickinson,
Franklin Lakes, NJ). Data analysis was performed by CellQuest
software (Becton-Dickinson, Franklin Lakes, NJ).
In vitro and in vivo differentiation of hESC
Embryoid bodies (EBs) were generated by aggregation of
hESCs and maintained in suspension as described before
(Itskovitz-Eldor et al., 2000) for 20 days. To produce terato-
mas, 2–3×106 hESCs were injected under the kidney capsule
of 6–8 weeks-old nude mice (Robertson, 1987). One month
later, mice were euthanized and teratomas collected, fixed
with 10% buffered formalin and embedded in paraffin. Four
microns sections were stained with hematoxilin and eosin
(H&E). Care of animals was in accordance with institutional
guidelines as approved by the Cedars-Sinai Medical Center
Institutional Animal Care and Use Committee, according-to-
protocol # 2182.
Statistics
Binomial test was used to determine frequencies ofmonosomy
and trisomy. Generalized estimation equations (GEE) were
applied to model the risk of monosomy or trisomy (in separate
models) in each chomosomewhile controlling for the repeated
measures within each embryo (SAS PROC GENMOD), using a
link-logit function and an unstructured correlation structure.
Contrasts of risk between each chromosome were estimated
and differences were considered significant where pb0.05.
Results and discussion
In order to derive hESCs with congenital aneuploidies, we
have analyzed 417 blastocyst-stage human embryos from
couples undergoing PGS, using probe panels covering up to
12 chromosomes (8, 13, 14, 15, 16, 17, 18, 20, 21, 22, X, Y
chromosomes). The total number of either monosomic or
trisomic events was 341 and 361, respectively. Analysis of
the number of events per chromosome indicates an overall
similar occurrence of monosomy and trisomy in each specific
chromosome in the cleavage-stage embryos, with the excep-
tion of chromosome 22 that has significantly more trisomy
than monosomy events (p=0.03) (Fig. 1A). However, the
incidence of numerical defects is different between chromo-
somes; for example, chromosomes 16 is significantly more
likely to present with a monosomy than chromosomes 8, 13,
15, 17, 20, 22, and X, while chromosome 21 will more likely
present with a trisomy than chromosomes 8, 15, 17, 20, and X
(Fig. 1A).
From 417 aneuploid embryos, we were able to derive 47
hESC lines; 25 of these cell lines were characterized before
(Biancotti et al., 2010), and 22 are described here (Supple-
mentary Table 1). In agreement to what we reported earlier
(Biancotti et al., 2010), about 2/3 of the new cell lines
developed into normal euploid cells, while the remnant 1/3
remained aneuploid, carrying trisomy of chromosome 21 (Down
syndrome, 2 lines), chromosome 20 (3 lines) or chromosome 12
Figure 1 Analysis of monosomies and trisomies in PGS embryos and karyotype of aneuploid hESCs. A. Total number of monosomies or
trisomies detected by PGS, arranged by chromosome. Only events correspondent to monosomies or trisomies were considered in the
quantification. Only chromosome 22 was found to present significantly more trisomy events than monosomy events (p=0.03). B.
Karyograms corresponding to the aneuploid hESC lines. Karyotype analysis was performed between passages 11 and 20. For most of the
cell lines, the karyotype was consistent in the 20 metaphases analyzed, with the exception of CSES41 (see Supplementary Table 1).
220 J.C. Biancotti et al.(1 line) as determined by karyotype analysis (Fig. 1B). All the
aneuploid hESC lines exhibit self-renewal capacity, express
typical markers of undifferentiated cells and have the ability to
differentiate into derivatives of the three embryonic germ
layers. In Fig. 2 we show alkaline phosphatase activity and
expression of Oct4 by immunocytochemistry for the aneuploid
cell lines. Analysis by flow cytometry revealed that on average
85% of the cells stained positive for SSEA4 and TRA-1-60 cell
surface antigens (Fig. 2). Pluripotency was determined by the
ability of the cells to differentiate in vitro into embryoid bodies
and in vivo into teratomas following injection under the kidney
capsule of immunocompromised mice (Fig. 3).
Next, we analyzed the ratio between the number of
events for each chromosome, and the number of aneuploid
hESC lines derived from these embryos. Fig. 4A shows that
blastomeres carrying an extra copy of either chromosomes
13, 16, 17, 20, 21 and X survived derivation and expansion in
culture and generated established hESC lines. However,
almost all human embryos with monosomies did not survive
the in vitro growth as ESC, with the exception of only one
hESC line with monosomy of chromosome X being generated
(Fig. 4B). Our inability to generate monosomic hESCs persists
whether we use immunologic or manual techniques to derive
the cells (see Materials and methods). Monosomy X (Turnersyndrome) is the only monosomy found in live humans, and the
one generated as hESC line. Although most X0 embryos are
spontaneously aborted during the first trimester of preg-
nancy, females with Turner syndrome that survive develop
almost normally with minor phenotypic features (Saenger,
1996). In addition, inactivation of an X chromosome in
females parallels to some extent the lack of an X chro-
mosome, except for the fact that X inactivation is not
complete leaving pseudoautosomal genes transcriptionally
active. Haploinsufficiency of pseudoautosomal genes in-
volved in development, was suggested to be the cause for
both, early lethality of monosomic embryos and phenotype
of surviving individuals (Zinn and Ross, 1998; Urbach and
Benvenisty, 2009). The bias against autosomal monosomies
indicates that the lack of an autosomal chromosome is
critical for cell survival and development.
Based on the ability to derive hESC lines with an extra
copy of a particular chromosome, the different trisomies
can be divided in two groups. One group comprises trisomies
for those chromosomes found to be present in blastomeres
by PGS, but unlikely to survive as trisomic ESC lines. This is
the case of trisomies 8, 14, 15, 18 and 22. The second group
clusters trisomies of chromosomes that are present in blasto-
meres and survive as ESC lines, such as trisomies 12, 13, 16,
Figure 2 Aneuploid hESC lines express markers of undifferentiated cells. Panels A-F correspond to staining for alkaline phosphatase
activity, and panels G-L in green or red, to immunostaining for Oct4. The six aneuploid cell lines are depicted as follows: CSES32 (A,
G), CSES36 (B, H), CSES40 (C, I), CSES41 (D, J), CSES44 (E, K), and CSES45 (F, L). All cell lines were grown on feeder layer composed of
mouse embryonic fibroblasts (MEF) as seen in the background of panels A–F. (M) Results of flow cytometry analysis displaying the
percentage of SSEA3/4 and TRA-1-60 single-staining positive cells. Bars in A–F=100 μm and in G–L=50 μm.
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in the derivation. Particularly, trisomies 17 and 20 seem to
have a better chance to survive as ESC lines. Interestingly,
these chromosomal alterations also frequently occur during
cellular adaptation of embryonic stem cells (Amps et al., 2011;
Ben-David et al., 2011; Baker et al., 2007; Mayshar et al., 2010).
There are cases in which the chromosomal abnormality
detected by karyotype of the hESC line does not match theresult of PGS, i.e. CSES36 and CSES41 have a PGS with +22
and a karyotype for the hESC line with no +22 but +20
instead (Supplementary Table 1). This lack of correspon-
dence between PGS and karyotype may be due in part to the
limitations of the PGS analysis, the occurrence of erroneous
results, and to the high incidence of mosaicism in early-
stage embryos. In our analysis of euploid hESCs derived from
aneuploid embryos, we did not detect the occurrence of
Figure 3 In vitro (embryoid bodies) and in vivo (teratomas) differentiation of aneuploid human embryonic stem cells. Panels A–F
correspond to 20 days embryoid bodies and panels G–L to H&E-stained sections of 30 days teratomas for the six aneuploid cell lines.
(A, G) CSES32; (B, H) CSES36; (C, I) CSES40; (D, J) CSES41; (E, K) CSES44; (F, L) CSES45. Bars in A, B, E=200 μm, in C, D, F=100 μm,
and in G–L=100 μm.
222 J.C. Biancotti et al.uniparental disomy as consequence of duplication or loss of
a whole chromosome (Lavon et al., 2008), supporting the
notion of high incidence of mosaicism in human embryos.
ESCs appear to be very sensitive to haploinsufficiency. In
mice it has been demonstrated that monosomic embryos die in
utero (Magnuson et al., 1982; Baranov, 1983a; Magnuson et al.,
1985). Our results suggest that human monosomic embryonic
cells at early stages of their development cannot survive even
in culture. Furthermore, trisomies are the most frequent
type of aneuploidy found in human spontaneous miscar-
riages, usually occurring during the first trimester of pregnan-
cy (Fritz et al., 2001; Jobanputra et al., 2002; Stephenson et
al., 2002; Vorsanova et al., 2005). Considering that trisomies
and monosomies occur at approximately the same rate inembryos at the blastocyst stage, the above mentioned
evidence suggests that cells with monosomies of autoso-
mal chromosomes are not viable and die early during the
peri-implantation period. One possible explanation for this lack
of viability is the loss of imprinted genes due to the missing
chromosome. However, human parthenogenetic ES and in-
duced pluripotent stem (iPS) cells survive and differentiate in
culture (Stelzer et al., 2011; Turovets et al., 2011; Brevini et
al., 2009), arguing against imprinting as the barrier in survival
of the monosomic ESC lines. Another possibility is that 50%
reduction in gene expression of critical loci scattered over all
the autosomes is responsible for the non-viability of the
embryos. In support of this hypothesis stand the facts that
dosage alteration of gene expression also appears to be the
Figure 4 Aneuploid human ES cell lines derived from PGS
embryos. A) Red bars represent the percentage of events for each
specific trisomy as diagnosed by PGS (% events for a trisomy=
number of events for a trisomy/number of events for all
trisomies×100), and grey bars the percentage of trisomic human
ES cell lines derived from PGS embryos (% hESC lines=number of
hESC lineswith a trisomy/number of events for that trisomy×100).
B) Blue bars stand for the percentage of monosomic events for each
chromosome (% events for a monosomy=number of events for a
monosomy/number of events for all monosomies×100), and grey
bars the percentage of monosomic human ES cell lines derived
from PGS embryos (% hESC lines=number of hESC lines with
a monosomy/number of events for that monosomy×100).
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al., 2010), and that chromosomal haploinsufficiency has already
been suggested to play a role in early lethality inmice (Baranov,
1983b; Schimenti et al., 2000). There is, however, occurrence
of partial deletions in autosomal chromosomes, which origi-
nates partial monosomies that are responsible for a variety of
diseases in humans.
Unlike monosomies, an extra copy of an autosomal chromo-
some seems to less dramatically affect the development of the
embryo. This is supported by the fact that full trisomies of
chromosomes 13, 18 and 21 can be seen in live births, although
with major phenotype, and usually early death. We have
demonstrated that trisomic hESC lines can be derived from
PGS embryos and maintained in culture. However, there is a
subgroup of trisomies detected by PGS that failed to generate
ESC lines. Most unexpected is the case of trisomy 18, in view of
the potential to engender live offspring (Edwards syndrome).
Yet,most of trisomy 18 conceptions spontaneously abort during
the first trimester (Hook, 1983). More importantly, althoughchromosome 18 abnormalities have been found in hESC lines
during cellular adaptation, these are deletions rather than
duplications, suggesting that a loss and not a gain in
chromosome 18 confers growth advantage in culture (Amps
et al., 2011). What causes that certain trisomic cells survive
and develop in culture whereas others die, is not fully
understood. Another question that arises is how a chromosomal
duplication, such as trisomy 21, can have so distinct pheno-
types, from early death and miscarriage to full development
with mild alterations. These questions remain unanswered,
although the study ofmultiple hESC lines with the same trisomy
may shed some light on the existence of genetic and/or
epigenetic differences between phenotypes.Author contribution
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